found that IL4I1 levels increased in the serum of CLL mice, indicating that IL4I1 could extend AhR activation effects from a local to a systemic level, better facilitating the creation of a supportive environment for tumor growth in metastatic sites [8]. Here, IL4I1 is linked to B-cell chronic lymphocytic leukemia.